ACADIA Pharmaceuticals Inc (ACAD)
16.33
-0.26
(-1.57%)
USD |
NASDAQ |
Apr 25, 16:00
16.35
+0.02
(+0.12%)
After-Hours: 20:00
ACADIA Pharmaceuticals Cash and Short Term Investments (Quarterly): 438.86M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 438.86M |
| September 30, 2023 | 345.92M |
| June 30, 2023 | 375.38M |
| March 31, 2023 | 402.87M |
| December 31, 2022 | 416.82M |
| September 30, 2022 | 436.58M |
| June 30, 2022 | 436.35M |
| March 31, 2022 | 445.98M |
| December 31, 2021 | 520.71M |
| September 30, 2021 | 540.29M |
| June 30, 2021 | 556.92M |
| March 31, 2021 | 577.77M |
| December 31, 2020 | 631.96M |
| September 30, 2020 | 644.44M |
| June 30, 2020 | 658.55M |
| March 31, 2020 | 651.41M |
| December 31, 2019 | 697.43M |
| September 30, 2019 | 683.85M |
| June 30, 2019 | 381.89M |
| March 31, 2019 | 414.32M |
| December 31, 2018 | 473.52M |
| September 30, 2018 | 214.14M |
| June 30, 2018 | 256.86M |
| March 31, 2018 | 298.06M |
| December 31, 2017 | 341.34M |
| Date | Value |
|---|---|
| September 30, 2017 | 366.62M |
| June 30, 2017 | 417.32M |
| March 31, 2017 | 469.48M |
| December 31, 2016 | 529.04M |
| September 30, 2016 | 588.86M |
| June 30, 2016 | 412.56M |
| March 31, 2016 | 457.24M |
| December 31, 2015 | 215.13M |
| September 30, 2015 | 240.69M |
| June 30, 2015 | 270.78M |
| March 31, 2015 | 297.89M |
| December 31, 2014 | 322.49M |
| September 30, 2014 | 337.80M |
| June 30, 2014 | 354.45M |
| March 31, 2014 | 369.28M |
| December 31, 2013 | 185.79M |
| September 30, 2013 | 196.18M |
| June 30, 2013 | 205.45M |
| March 31, 2013 | 101.46M |
| December 31, 2012 | 107.97M |
| September 30, 2012 | 23.06M |
| June 30, 2012 | 21.35M |
| March 31, 2012 | 25.92M |
| December 31, 2011 | 31.05M |
| September 30, 2011 | 36.15M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
345.92M
Minimum
Sep 2023
697.43M
Maximum
Dec 2019
518.10M
Average
520.71M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 24.95M |
| Amylyx Pharmaceuticals Inc | 371.36M |
| Regulus Therapeutics Inc | 23.77M |
| Minerva Neurosciences Inc | 40.91M |
| Viking Therapeutics Inc | 362.08M |